For immediate release
17 March
2023
THE BIOTECH GROWTH TRUST PLC
(the
"Company")
MARKET PURCHASE OF
COMPANY’S OWN SHARES
Notification is given, pursuant to the authority granted at
Annual General Meeting of the Company held on 19 July 2022 to make market purchases of the
Company’s own shares up to an aggregate maximum of 6,134,167 that a
market total of 37,201 Ordinary shares of 25p each in the capital
of the Company were purchased today for cancellation by the Company
at a price of 826.13 pence per
share.
Following this transaction and in conformity with the provisions
of the Transparency Directive, the Company hereby notifies the
market that the total number of Ordinary shares that the Company
has in issue, less the total number of Ordinary shares bought back
for cancellation by the Company following such purchase, and
therefore, the total number of voting rights in the Company is
39,053,270. The Company does not currently hold any Ordinary shares
in treasury.
The figure of 39,053,270 may be used by shareholders as the
denominator for the calculation by which they may determine if they
are required to notify their interest in, or change to their
interest in, the Company under the FCA’s Disclosure Guidance and
Transparency Rules.
For and on behalf of
Frostrow Capital LLP
Company Secretary
For further information, please contact:
Mark Pope
Frostrow Capital LLP
Tel: 020 3 170 4913